In vitro evaluation of a novel chemotherapeutic agent, NecroX-7, in human Burkitt lymphoma cells

被引:1
|
作者
Kim, Eun-Jung [1 ]
Lee, Eun Sol [1 ]
Im, Keon-Il [1 ]
Kim, Soon H. [2 ]
Lim, Jung-Yeon [1 ]
Kim, Nayoun [1 ]
Cho, Seok-Goo [3 ]
机构
[1] Catholic Univ Korea, CRCID, Lab Immune Regulat, Coll Med, Seoul, South Korea
[2] LG Life Sci Ltd, R&D Pk, Taejon, South Korea
[3] Catholic Univ Korea, Coll Med, Catholic Blood & Marrow Transplantat Ctr, Lab Immune Regulat,CRCID, Seoul, South Korea
关键词
D O I
10.1158/1538-7445.AM2014-2720
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2720
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Taurolidine: A novel chemotherapeutic agent which induces caspase-dependent apoptosis in human multiple myeloma cells.
    Martin, PB
    Goulette, FA
    Calabresi, P
    Cousens, L
    Darnowski, JW
    Rosmarin, AG
    Chatterjee, D
    BLOOD, 2001, 98 (11) : 310B - 310B
  • [32] Efficacy of a Novel Oral Chemotherapeutic Agent, TAS-102, Against Human Oral Squamous Cell Carcinoma Cells
    Harada, Koji
    Ferdous, Tarannum
    Mishima, Katsuaki
    ANTICANCER RESEARCH, 2021, 41 (12) : 6039 - 6049
  • [33] Imperatorin as a Promising Chemotherapeutic Agent against Human Larynx Cancer and Rhabdomyosarcoma Cells
    Grabarska, Aneta
    Skalicka-Wozniak, Krystyna
    Kielbus, Michal
    Dmoszynska-Graniczka, Magdalena
    Miziak, Paulina
    Szumilo, Justyna
    Nowosadzka, Ewa
    Kowalczuk, Krystyna
    Khalifa, Sherief
    Smok-Kalwat, Jolanta
    Klatka, Janusz
    Kupisz, Krzysztof
    Polberg, Krzysztof
    Rivero-Muller, Adolfo
    Stepulak, Andrzej
    MOLECULES, 2020, 25 (09):
  • [34] Marsdenia tenacssima extract and its functional components inhibits proliferation and induces apoptosis of human Burkitt leukemia/lymphoma cells in vitro and in vivo
    Li, Dong
    Li, Cuiping
    Song, Yanzhi
    Zhou, Min
    Sun, Xuemei
    Zhu, Xuejun
    Zhang, Fan
    Zhou, Chen
    Huan, Yahong
    Xia, Suqin
    Zhuo, Xingli
    Dong, Ping
    Sui, Xuemei
    Liao, Haiying
    Yang, Zhong-Fa
    LEUKEMIA & LYMPHOMA, 2016, 57 (02) : 419 - 428
  • [35] Design, Synthesis and Biochemical Evaluation of Novel Ethanoanthracenes and Related Compounds to Target Burkitt's Lymphoma
    Byrne, Andrew J.
    Bright, Sandra A.
    McKeown, James P.
    O'Brien, John E.
    Twamley, Brendan
    Fayne, Darren
    Williams, D. Clive
    Meegan, Mary J.
    PHARMACEUTICALS, 2020, 13 (01)
  • [36] EVALUATION OF INHIBITION OF HUMAN TUMOR TISSUE BY CANCER CHEMOTHERAPEUTIC DRUGS WITH AN IN VITRO TEST
    DIPAOLO, JA
    DOWD, JE
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1961, 27 (04) : 807 - &
  • [37] Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
    AL Dufresne
    D Fu
    RF Ambinder
    Infectious Agents and Cancer, 4 (Suppl 2)
  • [38] Medroxyprogesterone acetane and the PPARα ligand clofibric acid inherit the in vitro proliferation of Burkitt lymphoma cells.
    Mustard, KJW
    Bunce, CM
    Drayson, MT
    Gordon, J
    Pound, JD
    BRITISH JOURNAL OF CANCER, 1999, 80 : 47 - 47
  • [39] A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo
    Mata, JE
    Joshi, SS
    Palen, B
    Pirruccello, SJ
    Jackson, JD
    Elias, N
    Page, TJ
    Medlin, KL
    Iversen, PL
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 144 (01) : 189 - 197
  • [40] The P2X7 receptor enhances sensitivity to chemotherapeutic drugs in lymphoma cells
    Labitzky, Vera
    Becher, Janne
    Danquah, Welbeck
    Koch-Nolte, Friedrich
    Haag, Friedrich
    PURINERGIC SIGNALLING, 2014, 10 (04) : 730 - 730